Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

ETICOVO

ETANERCEPT-YKRO

Standard Dose
25MG/0.5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ETICOVO is listed in Drugs@FDA under application 761066 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ETANERCEPT-YKRO Form and strength INJECTABLE;INJECTION - 25MG/0.5ML Sponsor SAMSUNG BIOEPIS CO LTD Submission history Latest submission status date: 2025-12-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview ETICOVO is listed in Drugs@FDA under application 761066 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ETANERCEPT-YKRO Form and strength INJECTABLE;INJECTION - 25MG/0.5ML Sponsor SAMSUNG BIOEPIS CO LTD Submission history Latest submission status date: 2025-12-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
ETICOVO (ETANERCEPT-YKRO) | Drug Monograph | MedicHelpline